Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Monoclonal antibody (mAb) 5C3 directed against human p140 TrkA is a structural and functional mimic of nerve growth factor (NGF) and an artificial receptor agonist. mAb 5C3 binds in the NGF-docking site and, like NGF, it promotes TrkA internalization, TrkA and phosphatidylinositol-3 kinase tyrosine phosphorylation, and increased transformation of TrkA-expressing fibroblasts. More important, mAb 5C3 protects human TrkA-expressing cells from apoptotic death in serum-free media. Interestingly, agonistic activity is observed with monomeric F(ab) 5C3 fragments. mAb 5C3 (Kd approximately 2 nM) was used to study features of ligand binding by TrkA and the distribution of TrkA protein in normal human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dimerization of cell surface receptors in signal transduction
Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
Cited by
Neurotrophins and Time: Different Roles for TrkB Signaling in Hippocampal Long-Term Potentiation
Kang, H., Welcher, A. A., Shelton, D., & Schuman, E. M. (1997) · Neuron · doi:10.1016/s0896-6273(00)80378-5 · Cited by 481
“Characterization of Anti-TrkB Antisera the Trk receptors can act as either agonists or antago(A ) Anti-TrkB antisera block BDNF-induced TrkB phosphorylation in nists (Clary et al., 1994; LeSauteur et al., 1996).”
Qian, M. D., Zhang, J., Tan, X.-Y., Wood, A., Gill, D., & Cho, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1118-06.2006 · Cited by 67
“In contrast, treatment of HEKTrkA cells with NGF and HEK-TrkC cells with NT-3 resulted in dose-dependent increases in their luciferase activities, suggesting the intactness of the cellular signaling system (Fig.”
BackgroundInfluentialChen, D., Brahimi, F., Angell, Y., Li, Y.-C., Moscowicz, J., Saragovi, H. U., & Burgess, K. (2009) · ACS Chemical Biology · doi:10.1021/cb9001415 · Cited by 56
Self-citationCazorla, M., Arrang, J., & Prémont, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01094.x · Cited by 35
Metadata
- Authors
- LeSauteur, L., Maliartchouk, S., Le Jeune, H., Quirion, R., & Saragovi, H.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1996-02-15
- Volume
- 16
- Issue
- 4
- Pages
- 1308-1316
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2171104778
- Cited by
- 65
- References
- 2
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. https://app.cochat.ai/papers/10.1523/jneurosci.16-04-01308.1996
- The paper
- LeSauteur, L., Maliartchouk, S., Le Jeune, H., Quirion, R., & Saragovi, H. (1996). Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.16-04-01308.1996
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.